孤独症谱系障碍患者脑内神经代谢物水平的质子磁共振波谱研究荟萃分析
该研究对54项质子磁共振波谱研究进行荟萃分析,比较孤独症谱系障碍(ASD)患者与健康对照的脑内神经代谢物水平。结果显示ASD患者灰质和白质中NAA、Cho、Glx等代谢物水平及比值降低,额叶皮层GABA水平下降而Glu升高,年龄与部分代谢物效应量相关。
要点
- ASD患者灰质NAA、Cho水平及NAA/Cr比值降低,白质NAA和Glx水平降低。
- ASD患者额叶皮层NAA、GABA水平及NAA/Cr、GABA/Cr比值降低,前额叶皮层Glu水平升高。
- 年龄与灰质NAA和白质Glx的效应量呈正相关,提示年龄是混杂因素。
核心结论
- 特定脑区神经代谢物改变与ASD相关,年龄是某些代谢物水平的混杂因素。
研究设计与样本
- 系统检索PubMed和Web of Science,纳入54项质子磁共振波谱研究进行随机效应荟萃分析,总样本量N=1501。
主要发现
- 与健康对照相比,ASD患者灰质NAA和Cho水平及NAA/Cr比值降低,白质NAA和Glx水平降低。
- ASD患者额叶皮层NAA、GABA水平及NAA/Cr、GABA/Cr比值显著降低,前额叶皮层Glu水平升高。
- ASD患者颞叶皮层NAA水平和GABA/Cr比值降低,顶叶及背外侧前额叶皮层NAA水平和NAA/Cr比值降低,小脑和枕叶皮层NAA水平降低。
- 荟萃回归分析显示年龄与灰质NAA和白质Glx分析的效应量呈正相关。
临床怎么用
- 提示临床可关注ASD患者特定脑区神经代谢物改变,但尚不能作为诊断标志物。
- 年龄可能影响ASD患者神经代谢物水平,结果解读时需考虑年龄因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evidence suggests that neurometabolite alterations may be involved in the pathophysiology of autism spectrum disorders (ASDs). We performed a meta-analysis of proton magnetic resonance spectroscopy (1H-MRS) studies to examine the neurometabolite levels in the brains of patients with ASD. A systematic search of PubMed and Web of Science identified 54 studies for the meta-analysis. A random-effects meta-analysis demonstrated that compared with the healthy controls, patients with ASD had lower N-acetyl-aspartate-containing compound (NAA) and choline-containing compound (Cho) levels and NAA/(creatine-containing compound) Cr ratios in the gray matter and lower NAA and glutamate + glutamine (Glx) levels in the white matter. Furthermore, NAA and gamma-aminobutyric acid (GABA) levels, NAA/Cr ratios, and GABA/Cr ratios were significantly decreased in the frontal cortex of patients with ASD, whereas glutamate (Glu) levels were increased in the prefrontal cortex. Additionally, low NAA levels and GABA/Cr ratios in the temporal cortex, low NAA levels and NAA/Cr ratios in the parietal and dorsolateral prefrontal cortices, and low NAA levels in the cerebellum and occipital cortex were observed in patients with ASD. Meta-regression analysis revealed that age was positively associated with effect size in studies analyzing the levels of gray matter NAA and white matter Glx. Taken together, these results provide strong clinical evidence that neurometabolite alterations in specific brain regions are associated with ASD and age is a confounding factor for certain neurometabolite levels in patients with ASD.
引用
- Du Y, Chen L, Yan MC, et al. Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501). Mol Psychiatry. 2023. PMID: 37117459. doi:10.1038/s41380-023-02079-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。